TofacitinibTofacitinib, sold under the brand Xeljanz, Neojanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular-course juvenile idiopathic arthritis, and ulcerative colitis. Read from the Drugbox of the Wikipedia article Tofacitinib, revision 1371080185.

Property

Value

Formula

C16H20N6O, 312.38 g/mol

Bioavailability

74 %

Protein binding

40 %

Elimination half-life

3 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.